HEALTH● LOWSep 29 · Sep 29, 2026, 7:14 AM
Lilly’s Foundayo 17.2 mg beats oral semaglutide 25 mg on weight loss
Seeking Alpha Tech · global
Lilly's Foundayo 17.2 mg has demonstrated superior efficacy over oral semaglutide 25 mg in achieving weight loss, indicating a notable development in obesity treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoEven after explosive diarrhea outbreak Trump’s FDA looks to ease food requirementsThe Independent WorldHEALTH3h agoPope Leo recovers after lung surgeryNBC NewsHEALTH3h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH3h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News Daily